Celebrating Different level healthcare communicators in 2022
- PMLiVE
Stay updated with breaking news from Difference Collective. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Arquer Diagnostics' ADXBLADDER Becomes First Bladder Cancer Urine Test To Undergo Rigorous Clinical Trials In USA First patients recruited for bladder cancer recurrence monitoring study News provided by Share this article SUNDERLAND, England, July 27, 2021 /PRNewswire/ -- ADXBLADDER has become the first new generation urinary biomarker test for bladder cancer to undergo rigorous clinical trials in the USA in decades. The innovative and highly accurate test, developed by UK company Arquer Diagnostics, is already approved for use across Europe. ADXBLADDER is now being evaluated in a bladder c...